Evidence map›Paper›PMID 27884810›Full record

ArticleJournal of medical Internet research2016

Mobile Apps in Oncology: A Survey on Health Care Professionals' Attitude Toward Telemedicine, mHealth, and Oncological Apps.

Kerstin A Kessel, Marco M E Vogel, Friederike Schmidt-Graf, Stephanie E Combs

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
20.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Mobile applications in radiation oncology-current choices and future potentials.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Oncologic treatment support via a dedicated mobile app: a prospective feasibility evaluation (OPTIMISE-1).Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  15. Article
  16. Article
  17. An investigation of the use of app technology to support clinical management of patients with chronic myeloid leukaemia (CML).Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kerstin A KesselKlinikum rechts der Isar, Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.ORCID 0000-0002-6544-8151
Marco M E VogelKlinikum rechts der Isar, Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.ORCID 0000-0003-2942-6761
Friederike Schmidt-GrafKlinikum rechts der Isar, Department of Neurology, Technical University of Munich (TUM), Munich, Germany.ORCID 0000-0002-3515-4427
Stephanie E CombsKlinikum rechts der Isar, Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.ORCID 0000-0002-6934-2864
TUM Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMobile apps are an evolving trend in the medical field. To date, few apps in an oncological context exist.

objectiveThe aim was to analyze the attitude of health care professionals (HCPs) toward telemedicine, mHealth, and mobile apps in the field of oncology.

methodsWe developed and conducted an online survey with 24 questions evaluating HCPs' general attitude toward telemedicine and patients using medical mobile apps. Specific questions on the possible functionality for patients and the resulting advantages and disadvantages for both the patients' and HCPs' daily clinical routine were evaluated.

resultsA total of 108 HCPs completed the survey. In all, 88.9% (96/108) considered telemedicine useful and 84.3% (91/108) supported the idea of an oncological app complementing classical treatment. Automatic reminders, timetables, and assessment of side effects and quality of life during therapy were rated as the most important functions. In contrast, uncertainty regarding medical responsibility and data privacy were reasons mostly named by critics. Most (64.8%, 70/108) were in favor of an alert function due to data input needing further clarification, and 94% (66/70) were willing to contact the patient after a critical alert. In all, 93.5% (101/108) supported the idea of using the collected data for scientific research. Moreover, 75.0% (81/108) believed establishing a mobile app could be beneficial for the providing hospital.

conclusionsA majority of HCPs are in favor of telemedicine and the use of oncological apps by patients. Assessing side effects can lead to quicker response and thus lower inconvenience for patients. Clinical data, such as life quality and treatment satisfaction, could be used to evaluate and improve the therapy workflow. Eventually, a mobile app would enhance the patients' relationship to their treating department because they are in permanent contact.

Indexed as

Attitude of Health PersonnelMobile ApplicationsAdolescentAdultAgedAged, 80 and overHealth PersonnelHumansMiddle AgedQuality of LifeSurveys and QuestionnairesTelemedicineYoung AdultappeHealthmHealthmobile applicationoncologypatient-reported outcomesmartphonetelemedicine

Identifiers

PMID27884810
PMCPMC5146327
OpenAlexW2551669909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.